African Journal of Microbiology Research · 2011 · 27 citations · 16 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceBacteriologyMedical MicrobiologyAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance MechanismsAntimicrobial Susceptibility TestingBeta-lactam ResistanceMultidrug ResistanceAntimicrobial Resistance Gene DetectionBacterial Multidrug ResistanceBacterial Resistance DetectionBeta-lactamase GenesDisk Diffusion TestingExtended-spectrum Beta-lactamase ProductionExtended-spectrum Beta-lactamase-producing OrganismsPseudomonas Aeruginosa Resistance
Pseudomonas aeruginosa is the most common pathogen causing nosocomial infections. The objective of this study was to investigate the extended-spectrum-beta-lactamase (ESBLs) producing and multidrug resistance of hospital isolates of P. aeruginosa and to determine the presence of several resistance genes. A total of 86 isolates of P. aeruginosa were collected from teaching hospital in Kashan, Iran. Susceptibility to eight antimicrobial agents was performed by disk diffusion method. ESBL-phenotypic detection was carried out by double-disk synergy test; and the presence of the genes encoding ofbla(TEM), bla(SHV), bla(CTX-M), bla(OXA) and bla(GES)-like genes was studied by polymerase chain reaction. The prevalence of ESBLs was 8.1%. The presence of genes encoding ESBLs was confirmed in seven isolates, comprising seven bla(GES-2), onebla(SHV-1), one bla(SHV-5) and one bla(CTX-M-1) genes. P. aeruginosa demonstrated the highest resistance rate to piperacillin (38.4%), 67.5% of isolates were sensitive to imipenem whereas 32.5% were MDR (resistant to three or more classes of antibiotics). A multidrug-resistant (MDR) phenotype occurred frequently in P. aeruginosa. bla(GES-2), which compromises the efficacy of imipenem detected in all of seven ESBL-producing P. aeruginosa strains. Proper infection control practices and barriers are essential to prevent spreading and outbreaks of ESBL-producing and MDR P. aeruginosa in our teaching hospital. Key words: Pseudomonas aeruginosa, extended-spectrum-beta-lactamase, multidrug-resistant.
16
Vincent Jarlier, M. H. Nicolas, G. Fournier et al. · Clinical Infectious Diseases · 1988 · 1.6K citations
David L. Paterson, Kristine M. Hujer, Andrea M. Hujer et al. · Antimicrobial Agents and Chemotherapy · 2003 · 400 citations · Full text
George G. Zhanel, Melanie DeCorby, Heather J. Adam et al. · Antimicrobial Agents and Chemotherapy · 2010 · 170 citations · Full text
Laurent Poirel, Thierry Naas, Isabelle Thomas et al. · Antimicrobial Agents and Chemotherapy · 2001 · 157 citations · Full text